HEB Pharmacy Conference October 25, 2014
|
|
- Marshall Floyd
- 5 years ago
- Views:
Transcription
1 Texas State Board of Pharmacy Laws and Rules Update Allison Benz, R.Ph., M.S. Director of Professional Services Central Texas Society of Health-System Pharmacists Annual Seminar October 25, 2014 Texas State Board of Pharmacy 1
2 Goals Review recent changes to pharmacy rules; Talk about some issues facing the Board; Review some possible legislation that may be introduced during the 2015 Legislative Session; and Answer your questions. 8 Texas State Board of Pharmacy Board of Pharmacy Members Jeanne D. Waggener, R.Ph. President Waco Dennis F. Wiesner, R.Ph. Vice President Austin Buford T. Abeldt, Sr., R.Ph. Lufkin Treasurer Christopher M. Dembny, R.Ph. Richardson W. Benjamin Fry, R.Ph., FIACP, FACA San Benito L. Suzan Kedron Dallas Alice G. Mendoza, R.Ph. Kingsville Bradley A. Miller, Ph.T.R. Austin Phyllis A. Stine Abilene Joyce Tipton, R.Ph., MBA Houston Charles F. Wetherbee Boerne Class A (Community) and Class C (Institutional) Pharmacies Tramadol After 1/1/13, tramadol (Ultram ) is required to be inventoried on the initial, annual, change of ownership, and change of PIC inventories. After 6/1/13 the change of PIC inventory must include all controlled substances, nalbuphine, and tramadol. Tramadol became a schedule IV controlled substance on August 18, Texas State Board of Pharmacy 2
3 Delegation of Access to Prescription Access Texas (PAT) System S.B passed by the 2013 Texas Legislature amended the Texas Controlled Substances Act to allow a pharmacy technician working under the supervision of a pharmacist to query the PAT Program for the recent Schedule II-V prescription history of a particular patient. Note: DPS published adopted rules to implement this provision in the Texas Register on August 29, 2014 (effective September 7, 2014). Class A Pharmacies Notification When Substituting Dosage Forms Effective Date: September 1, 2013 S.B. 869 passed by the 2013 Texas Legislature amended the Pharmacy Act to delete the requirement for pharmacists to notify a practitioner when they substitute a dosage form. Rules were adopted by the Board at the August 5, Pharmacists and Pharmacy Technicians Pharmacist s Continuing Education Effective Date: 3/17/2013. Pharmacists can receive credit for programs approved by AMA as Category 1 CME. Pharmacists must report 1-hour of CE related to Texas Pharmacy Laws or Regulations on renewals received after 1/1/15. Pharmacy Technician Continuing Education Effective Date: 6/12/2013. Pharmacy Technicians must report 1-hour of CE related to Texas Pharmacy Laws or Regulations on renewals received after 1/1/15. Texas State Board of Pharmacy 3
4 Current Issues Schedule III V Controlled Substance Rxs from APRNs and PAs At their December 2013, meeting, the Texas Medical Board reviewed Section (b)(2) of the Medical Practices Act that reads: the prescription, including a refill of the prescription, is for a period not to exceed 90 days. TMB has determined that this section means that an APRN or PA may issue prescriptions for a total of 90 days supply of a controlled substance including refills. Schedule III V Rxs from APRNs and PAs (cont.) TMB stated that the intent of the section is to allow 90 days supply and not to limit the patient to one refill. This means the APRN or PA could issue a prescription with more than one refill provided the total quantity does not exceed more than a 90 day supply. Schedule III V Rxs from APRNs and PAs (cont.) Further discussions with staff of the Medical Board have also resulted in the interpretation that essentially a controlled substance prescription issued by an APRN or PA, expires 90 days after issuance. Hydrocodone Combination Products (HCP) Move to CII On 10/6/2014, all hydrocodone combination products will become schedule II controlled substances. Pharmacists are allowed to dispense any refills authorized on HCP prescriptions issued prior to 10/6/2014. Pharmacies must take an inventory of HCP on 10/6/2014. DEA Regulations on Disposal of Controlled Substance Effective Date: October 9, Authorizes certain DEA registrants, including pharmacies to become authorized collectors (Note: this will require modification of the DEA registration to obtain authorization to be a collector). Authorizes pharmacies to operate collection receptacles at long-term care facilities. Texas State Board of Pharmacy 4
5 Sterile Compounding Fungal Meningitis Outbreak 2012 New England Compounding Center (NECC) in Framingham, MA As of October 23, states had reported cases. 751 cases of fungal infections. 64 deaths. Priorities for Inspections Experiences Pharmacies that: Compound High Risk Preparations. Have had previous non-compliance problems during inspections. Compound Low and Medium Risk Preparations. As a result of recent inspections, 2-pharmacies were ordered to cease compounding of High-Risk preparations. Tools Available to TSBP shut down compounding operations: Issuance of a Warning Notice with immediate duedate (voluntary compliance). Summary Suspension of a license Texas Legislative Session 2013 Texas Legislative Session (cont.) The Texas Pharmacy Act was amended by SB 1100 to specify that: New pharmacies that compound sterile preparations may not be licensed by TSBP until the pharmacy has: been inspected to ensure the pharmacy meets the requirements of TSBP laws and rules; and reimbursed the Board for all expenses incurred in inspecting the pharmacy, if the pharmacy is located in another state. The Texas Pharmacy Act was amended by SB 1100 to specify that: Existing pharmacies that compounding sterile preparations may not renew their registration unless the pharmacy has: been inspected to ensure the pharmacy meets the requirements of TSBP laws and rules; and reimbursed the Board for all expenses incurred in inspecting the pharmacy, if the pharmacy is located in another state. Texas State Board of Pharmacy 5
6 2013 Texas Legislative Session (cont.) 2013 Texas Legislative Session (cont.) The Texas Pharmacy Act was amended by SB 1100 to specify that: A pharmacy that compounds a sterile product must notify the Board: Immediately of any adverse effects reported to the pharmacy or known by the pharmacy to be potentially attributable to a sterile product compounded by the pharmacy; and Not later than 24-hours after the pharmacy issues a recall for a sterile product compounded by the pharmacy. Through SB 1 TSBP was given additional appropriations to: Hire 6 additional personnel directly related to the inspection pharmacies that compound sterile preparations; and Additional funding to test sterile preparations compounded by pharmacies. Actions Since 2013 Session New rules for the operation of pharmacies that compound sterile preparations became effective 12/10/13. A new license designation has been created for pharmacies that compound sterile products (A-S, C-S, E-S. A new inspection form has been developed and is being tested. Actions Since 2013 Session (cont.) TSBP has hired 5 new inspectors and 1 administrative person to assist with inspections. By 9/30/2014, all inspectors will have received additional training for the inspecting of pharmacies that compound sterile preparations. Testing of Compounded Products SUMMARY OF COMPOUNDED SAMPLE TESTING PROGRAM FY 2009 FY 2013 FY2009 FY2010 FY2011 FY2012 FY Yr. Avg. Total # Samples Tested # Non-Sterile Samples Tested # Potency Failures # Sterile Samples Tested # Potency Failures # Sterility Failures ** 0 <1 # Fungal Failures * N/A N/A N/A N/A 0 0 # Endotoxin Failures * Fungal Testing began in FY2013 **Nasal product Federal Drug Quality and Security Act (DQSA) Texas State Board of Pharmacy 6
7 Drug Quality and Security Act (DQSA) Section 503A Pharmacy Compounding Signed into law on November 27, Title I Compounding Quality Act. Section 503A Pharmacy Compounding. Section 503B Outsourcing Facilities. Section 503A was amended to remove the advertising and solicitation provisions that were struck down as unconstitutional by the U.S. Supreme Court in With these provisions removed, this 1997 law will now become effective. Section 503A Pharmacy Compounding (cont.) Section 503A Pharmacy Compounding (cont.) 503A exempts pharmacy compounding from compliance three sections of the Federal law that manufacturers are required to meet: FDA approval of products prior to marketing; Labeling with adequate directions for use; and Compliance with Current Good Manufacturing Practices (CGMP). Pharmacy compounders: Are licensed as a pharmacy by a state; and May compound prescription drugs: Pursuant to a prescription for an individual patient; and In limited quantities, in anticipation of the receipt of a prescription. Section 503B Outsourcing Facilities Section 503B Outsourcing Facilities (cont.) An outsourcing facility will qualify for exemptions from the: FDA approval requirements; and requirement to label products with adequate directions for use; but not the exemption from CGMP requirements. Outsourcing facilities: Will be registered by FDA; Must comply with CGMP requirements; Will be inspected by FDA according to a risk-based schedule; and Must meet certain other conditions, such as reporting adverse events and providing FDA with certain information about the products they compound. Texas State Board of Pharmacy 7
8 Task Force on Pharmacy Technicians In November 2013, the Board directed staff to establish a Task Force on Pharmacy Technicians. Task Force on Pharmacy Technicians (cont.) Task Force on Pharmacy Technicians (cont.) The Task Force was charged with: reviewing the current laws and rules relating to technicians in Texas; reviewing literature and studies regarding the changing roles and duties of pharmacists and how these changes may impact the role of technicians; and making recommendations to the Board for any changes to the current technician laws and rules to allow technicians to assist pharmacists in providing safe and quality pharmaceutical care to the citizens of Texas. The Task Force met on: January 14, 2014; and March 19, The Recommendations of the Task Force were presented to the Board at their May 6, 2014 meeting. Recommendations The Board should continue requiring pharmacy technicians to take and pass one national certification examination. The Board should allow a Technician Trainee to renew their registration once so that their total time as a Technician Trainee will be 4-years rather than the current 2-years. The Board should review the definition of the definition of a pharmacy technician to better define what non-judgmental duties are and seek legislation to amend this definition in the Pharmacy Act. Texas State Board of Pharmacy 8
9 The Board shall establish a training program that the technician must complete prior to completing expanded duties. A technician may perform expanded duties provided the: technician completes Board established on-the-job training; training is documented by the PIC; and pharmacist on duty allows the technician to perform the expanded duties while that pharmacist is working. The Board should allow training exemptions from required training for expanded duties for technicians in rural areas. The Board should establish a method to grandfather currently registered technicians from the requirement to have completed an ASHP accredited technician education program after 2020 when PTCB will require completion of this program prior to taking the PTCB exam. The Board should amend rules or seek legislation if necessary to expand the duties of technicians to include: Expanding Tech Check Tech in hospital pharmacies and allowing Tech Check Tech in community pharmacies for such duties as: Stocking medication carts; Checking the prepacking of drugs; and Stocking automated dispensing systems. Expand the duties of technicians to include: Allowing technicians to: transfer refill prescriptions for dangerous drugs. data enter prescriptions in an area other than the prescription department prior to the opening of the pharmacy). perform a final check on a refilled prescription (Note: DUR by pharmacist will still be required). The task force members support the elimination of the ratio of pharmacists to technicians. Suggestions for Law Changes during the 2015 Legislative Session Effective Date: March Class A and B Pharmacies ratio of pharmacists to pharmacy technicians is increased to 1:4. Class G Pharmacies ratio of pharmacists to pharmacy technicians is increased to 1:8. Texas State Board of Pharmacy 9
10 Suggestions for Law Changes 2015 Legislative Session Suggestions for Law Changes (cont.) Self-Directed Semi-Independent Agency Status. Transfer the prescription monitoring program to TSBP. Amend the Pharmacy Act to allow the TSBP access to financial records. Expand the Board s inspection authority to include the ability copy and inspect the records of a pharmacist practicing outside a pharmacy. Eliminate the requirement for posting the Generic Substitution Sign and modify the requirement for the Complaint Notification to allow posting on an electronic bulletin board. Allow TSBP to close a pharmacy automatically if the pharmacy is: not open within a reasonable time after the license has been issued; or no longer operating. Suggestions for Law Changes (cont.) Class E (Out-of-State) Pharmacies: Require a Class E pharmacy to have a PIC who is licensed as a pharmacist in Texas; Prohibit a person who has had a pharmacist s license revoked, suspended, restricted, surrendered in another state from being an owner of a Class E Pharmacy. Allow the Board to discipline of a Class E pharmacy license if they have been disciplined for violating laws in their state. New Address and New Look for the TSBP Website Texas State Board of Pharmacy 10
11 Questions? Thank You! Texas State Board of Pharmacy 11
Board of Pharmacy Update
Board of Pharmacy Update Gay Dodson, R.Ph. Executive Director/Secretary Texas Pain Society s 6 th Annual Scientific Meeting October 26, 2014 Goals Review some recent changes to federal law. Review some
More informationTSBP Board of Pharmacy Update
TSBP Board of Pharmacy Update Allison Vordenbaumen Benz, R.Ph., M.S. Director of Professional Services Central Texas Society of Health-System Pharmacists San Antonio, Texas October 3, 2015 Goals Review
More informationTexas Pharmacy Law Update
Texas Pharmacy Law Update Allison Benz, Executive Director of the State Board of Pharmacy Presented by Alice Mendoza, R.Ph. State Board of Pharmacy Goals and Objectives Review recent changes in Texas Pharmacy
More information116th Annual Convention
116th Annual Convention Date: Monday, October 20, 2014 Time: 8:00 am 9:30 am Location: Austin Convention Center, Room 17AB, Level 4 Title: Activity Type: Speaker: Compounding - Important Developments That
More informationSECTION PRESCRIPTIONS
SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or
More informationTEXAS COMPASSIONATE-USE ACT
Ch. 301, 1 MEDICAL USE OF LOW-THC CANNABIS AND THE REGULATION OF RELATED ORGANIZATIONS AND INDIVIDUALS; REQUIRING A DISPENSING ORGANIZATION TO OBTAIN A LICENSE TO DISPENSE LOW-THC CANNABIS AND ANY EMPLOYEE
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationRULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-17 DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS 1140-17-.01 Definitions 1140-17-.02 Purpose 1140-17-.03 Eligibility Criteria for Program Participation
More informationAN ACT. relating to the medical use of low-thc cannabis and the regulation. of related organizations and individuals; requiring a dispensing
Chapter 0 S.B. No. AN ACT relating to the medical use of low-thc cannabis and the regulation of related organizations and individuals; requiring a dispensing organization to obtain a license to dispense
More informationDRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT
c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationAct 443 of 2009 House Bill 1379
Act 443 of 2009 House Bill 1379 AN ACT TO PROVIDE FOR THE LICENSURE OF ALCOHOLISM AND DRUG ABUSE COUNSELORS; TO PROVIDE FOR THE REGISTRATION OF CLINICAL ALCOHOLISM AND DRUG ABUSE COUNSELOR SUPERVISORS;
More information720 cases. 20 states. Conflict of Interest Declaration. New England Compounding Center (NECC) timeline. (NECC) timeline (continued) 3/28/2013
Conflict of Interest Declaration Compounding at a Crossroads: The Federal and State Outlook Christopher J. Topoleski has no actual or potential conflicts of interest in relation to this activity Christopher
More informationJanuary 2017 FEDERAL LAW CURRENT BOARD MEMBERS. June 24, Ben Kesner RPh Executive Director Shelley Bagwell RPh PMP Director.
June 24, 2017 Ben Kesner RPh Executive Director Shelley Bagwell RPh PMP Director CURRENT BOARD MEMBERS January 2017 Richard Mazzoni RPh Amy Buesing RPh Neal Dungan RPh Joe Anderson RPh Teri Rolan RPh Cathleen
More information2016 Jurisprudence Update. (Phone) (Fax)
2016 Jurisprudence Update (Phone) 614-466-4143 (Fax) 614-752-4836 www.pharmacy.ohio.gov Goals and Objectives To explain recent law/rule changes which may apply to the pharmacy practice setting. To describe
More informationDispensing and administration of emergency opioid antagonist without a
68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies
More informationFEDERAL LAW CURRENT BOARD MEMBERS. January 28, Drug Disposal. Ben Kesner Executive Director Cheranne McCracken State Drug Inspector
January 28, 2017 Ben Kesner Executive Director Cheranne McCracken State Drug Inspector CURRENT BOARD MEMBERS 2016 Richard Mazzoni RPh Amy Buesing RPh Neal Dungan RPh Joe Anderson RPh Teri Rolan RPh Cathleen
More informationThis Chapter Contains:
This Chapter Contains: State and Federal Laws Relating to Controlled Substances and Other Medications Drugs Used in Animal Shelters Acquiring Controlled Substances Record Keeping of Controlled Substances
More informationTSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17
TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild, Irvine, CA 92612-2506 Telephone: 949-608-2900 Fax: 949-608-4417 WARNING LETTER VIA SIGNATURE
More informationPHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998
PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998 Questions 1 20 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions
More informationChanges to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
More informationFL AT Act As amended 5/30/06 by Chapter (SB 366) (Amendments not noted; see SB 366 file for changes) PART XIII ATHLETIC TRAINERS
FL AT Act As amended 5/30/06 by Chapter 2006-39 (SB 366) (Amendments not noted; see SB 366 file for changes) PART XIII ATHLETIC TRAINERS 468.70 Legislative intent.--it is the intent of the Legislature
More informationControlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System
Controlled Substance Prescribing: A Physician s Guide Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Objectives Review schedules of controlled substances and their propensity for
More informationMinnesota. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Minnesota Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More information6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES
CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and
More informationGuidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance
More informationRhode Island. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationSENATE BILL No. 501 AMENDED IN SENATE MAY 1, 2017 AMENDED IN SENATE APRIL 20, 2017 AMENDED IN SENATE APRIL 17, Introduced by Senator Glazer
AMENDED IN SENATE MAY 1, 2017 AMENDED IN SENATE APRIL 20, 2017 AMENDED IN SENATE APRIL 17, 2017 SENATE BILL No. 501 Introduced by Senator Glazer February 16, 2017 An act to amend Sections 1601.4, 1646,
More informationNEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION
Chapter NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION EFFECTIVE: Policy REVISED: 4/13/9 draft NALOXONE DISTRIBUTION POLICY I. PURPOSE: This New Mexico Department of Health (NMDOH)
More informationSan Diego Compounding Pharmacy 9/25/17
San Diego Compounding Pharmacy 9/25/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild Road Los Angeles, CA 92612 WARNING LETTER VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED September
More informationNorth Dakota Board of Pharmacy
North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives
More informationOCCUPATIONAL AND PROFESSIONAL LICENSING OPTOMETRIC PRACTITIONERS CONTINUING EDUCATION
TITLE 16 CHAPTER 16 PART 13 OCCUPATIONAL AND PROFESSIONAL LICENSING OPTOMETRIC PRACTITIONERS CONTINUING EDUCATION 16.16.13.1 ISSUING AGENCY: New Mexico Board of Optometry. [10-14-95; 2-15-99; 16.16.13.1
More informationCHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 2760
CHAPTER 2008-64 Committee Substitute for Committee Substitute for Senate Bill No. 2760 An act relating to dentistry; amending s. 466.003, F.S.; providing a definition; amending s. 466.006, F.S.; revising
More informationWest Virginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationLegislative Counsel s Digest:
Senate Bill No. 250 Senator Carlton (by request) CHAPTER... AN ACT relating to dentistry and dental hygiene; revising various provisions governing the qualifications, examination and licensure of dentists
More informationSub. S.B. 119 As Passed by the Senate
AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,
More informationCHAPTER 40 PROFESSIONAL LICENSING AND FACILITY REGULATION
216-RICR-40-05-33 TITLE 216 - DEPARTMENT OF HEALTH CHAPTER 40 PROFESSIONAL LICENSING AND FACILITY REGULATION SUBCHAPTER 05 PROFESSIONAL LICENSING PART 33 - Speech Pathologists and Audiologists 33.1 Authority
More informationOklahoma. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationFor An Act To Be Entitled. Subtitle
0 0 State of Arkansas INTERIM STUDY PROPOSAL 0-0th General Assembly A Bill DRAFT JMB/JMB Second Extraordinary Session, 0 SENATE BILL By: Senator J. Hutchinson Filed with: Arkansas Legislative Council pursuant
More informationPLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.
PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to July 1, 2012. It is intended for information and reference purposes only. This
More informationA Bill Regular Session, 2015 SENATE BILL 717
Stricken language would be deleted from and underlined language would be added to present law. 0 State of Arkansas 0th General Assembly As Engrossed: S// H// A Bill Regular Session, SENATE BILL By: Senator
More informationPLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.
PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended for information and reference purposes only.
More informationH 7816 S T A T E O F R H O D E I S L A N D
LC00 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - PHARMACIES Introduced By: Representatives Serpa, Canario,
More informationTitle 32, Chapter 127-A, ATHLETIC TRAINERS (HEADING: PL 1995, c. (new))
Chapter 127-A: ATHLETIC TRAINERS 14351. Purpose The Legislature finds that the practice of athletic training affects the public health, safety and welfare and is subject to regulation and control in the
More informationTalon Compounding Pharmacy 10/3/17
Talon Compounding Pharmacy 10/3/17 Office of Pharmaceutical Quality Operations, Division II 4040 N. Central Expressway, Suite 300 Dallas, Texas 75204 October 3, 2017 CMS Case # 522630 VIA UPS EXPRESS WARNING
More informationMichigan Opioid Legislation Hospital Compliance Checklist
MHA KEYSTONE CENTER MICHIGAN OPIOID LEGISLATION HOSPITAL COMPLIANCE CHECKLIST The Michigan Opioid Legislation was created by the Michigan Health & Hospital Association to help guide its member hospitals
More informationSubstance Abuse Policy. Substance Abuse Policy for Employees and Students
College Rules and Regulations 2.2008.1 Substance Abuse Policy Substance Abuse Policy for Employees and Students I. Substance Abuse Policy for Employees and Students A. Purpose The County College of Morris
More informationTennessee. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationArkansas Pharmacy Law Update. John Clay Kirtley, Pharm.D. Assistant Director Arkansas State Board of Pharmacy
Arkansas Pharmacy Law Update John Clay Kirtley, Pharm.D. Assistant Director Arkansas State Board of Pharmacy Objectives Analyze recent changes in Pharmacy regulations in Arkansas Discuss the reasoning
More informationMISSOURI BOARD OF PHARMACY NEWSLETTER
MISSOURI BOARD OF PHARMACY NEWSLETTER FEBRUARY 2018 CONTENTS FY17 Annual Report...1 What Takes So Long?...3 Did You Know?...3 Inspection Tip...3 Rule Updates...5 Meet Our New Inspector!!...6 Disciplinary
More informationHistory Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013.
21 NCAC 46.1412 PHYSICAL REQUIREMENTS A health care facility pharmacy shall have sufficient floor space allocated to it to ensure that drugs are prepared in sanitary, well lighted, and enclosed places.
More informationISSUING AGENCY: Regulation and Licensing Department - NM Board of Osteopathic Medical Examiners.
Code of New Mexico Rules Title 16. Occupational and Professional Licensing Chapter 17. Osteopathic Medicine and Surgery Practitioners Part 5. Prescribing and Distribution of Controlled Substances 16.17.5.
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More informationOCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES
TITLE 16 CHAPTER 10 PART 14 OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES 16.10.14.1 ISSUING AGENCY: New
More informationCHAPTER Section 3 of P.L.1983, c.296 (C.45: ) is amended to read as follows:
CHAPTER 121 AN ACT concerning the practice of physical therapy, amending P.L.2003, c.18, and amending and supplementing P.L.1983, c.296. BE IT ENACTED by the Senate and General Assembly of the State of
More information10/10/2017. Disclosure
Disclosure Ronna Hauser, Vice President, Pharmacy Affairs, NCPA declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment,
More informationIC Chapter 1. Regulation of Chiropractors Creation of Board
IC 25-10 ARTICLE 10. CHIROPRACTORS IC 25-10-1 Chapter 1. Regulation of Chiropractors Creation of Board IC 25-10-1-1 Definitions Sec. 1. As used in this article: (1) "Chiropractic" means the diagnosis and
More informationPROPOSED REGULATION OF THE BOARD OF EXAMINERS FOR ALCOHOL, DRUG AND GAMBLING COUNSELORS LCB FILE NO. R069-17I
PROPOSED REGULATION OF THE BOARD OF EXAMINERS FOR ALCOHOL, DRUG AND GAMBLING COUNSELORS LCB FILE NO. R069-17I The following document is the initial draft regulation proposed by the agency submitted on
More informationMedicines and Cosmetics Regulation Unvalidated References:
Medicines and Cosmetics Regulation 2002 Unvalidated References: This reprint of this Statutory Instrument incorporates all amendments, if any, made before 25 November 2006 and in force at 16 May 2002....
More informationSUBJECT: Effective Date: Policy Number: Controlled Substance and Prescription Drugs 11/30/
Division of Research SUBJECT: Effective Date: Controlled Substance and Prescription Drugs 11/30/2018 Supersedes: Page Of 12/04/2015 04/25/2007 1 6 Responsible Authorities: Vice President, Research Institutional
More informationARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH
ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH 1.0 INTRODUCTION Arkansas State University (ASU) is committed to enhancing the growth of research and other
More informationUtah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
More informationVirginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More information45:14G-1 Short title. 1.This act shall be known and may be cited as the "Polysomnography Practice Act."
New Jersey Practice Act Contains a Polysomnography Licensure Practice Act "Polysomnography Practice Act" New Jersey Statutes TITLE 45 PROFESSIONS AND OCCUPATIONS 45:14G-1 45:14G-1 Short title. 1.This act
More informationNew Mexico. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationUse of Controlled Substances in Research.
3341-7-09 Use of Controlled Substances in Research. Applicability Faculty and staff who hold federal Drug Enforcement Administration (DEA) licenses to use controlled substances for research purposes. Responsible
More informationSecretary of the Senate. Chief Clerk of the Assembly. Private Secretary of the Governor
Senate Bill No. 132 Passed the Senate October 14, 2009 Secretary of the Senate Passed the Assembly September 8, 2009 Chief Clerk of the Assembly This bill was received by the Governor this day of, 2009,
More informationRecall Guidelines. for Chinese Medicine Products
Recall Guidelines for Chinese Medicine Products April 2018 Recall Guidelines for Chinese Medicine Products Chinese Medicines Board Chinese Medicine Council of Hong Kong Compiled in September 2005 1 st
More informationl. The North Carolina Board of Pharmacy is a body duly organized under the laws
' l BEFORE THE NORTH CAROLNA BOARD OF PHARMACY n the Matter of: TMOTHY H. CLARK (License No. 12114 CONSENT ORDER THS MATTER came on to be considered at a prehearing conference (hereinafter, "Conference"
More informationState, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP
State, District, or Territory Alabama Arizona Arkansas Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate, the applicant shall have a current
More informationAN ACT RELATING TO HEALTH CARE; ENACTING THE UNLICENSED HEALTH CARE BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
AN ACT RELATING TO HEALTH CARE; ENACTING THE UNLICENSED HEALTH CARE PRACTICE ACT; PROVIDING PENALTIES. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO: Section 1. SHORT TITLE.--This act may
More informationOn December 27, 2017, the Lieutenant Governor signed into law several new requirements
OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following
More informationStonegate Pharmacy LP 11/10/16
Stonegate Pharmacy LP 11/10/16 November 10, 2016 2017 DAL WL 03 WARNING LETTER UPS Overnight Rene F. Garza, Pharm.D., Chief Executive Officer Stonegate Pharmacy, LP 2501 W. William Cannon Drive, Suite
More informationChapter 5. Practicing Optometry
Chapter 5. Practicing Optometry 501. Professional Conduct A. The optometrist shall keep the visual welfare of the patient uppermost at all times, promote the best care of the visual needs of mankind, strive
More informationSOUTH DAKOTA BOARD OF REGENTS. Policy Manual
SUBJECT: Drug Free Environment NUMBER: 4:27 SOUTH DAKOTA BOARD OF REGENTS Policy Manual Drug Free Workplace Policy The South Dakota Board of Regents is committed to providing a drug free workplace. Additional
More informationGood Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions
Good Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions Research current through January 21, 2015 This project was supported by Grant No. G1399ONDCP03A, awarded by the Office
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More informationTITLE 54. PROFESSIONS, VOCATIONS, AND BUSINESSES CHAPTER 43: RESPIRATORY CARE PRACTICE ACT A. POLYSOMNOGRAPHY RELATED RESPIRATORY CARE.
Idaho Statutory Language Idaho Statutes: TITLE 54. PROFESSIONS, VOCATIONS, AND BUSINESSES CHAPTER 43: RESPIRATORY CARE PRACTICE ACT 54-4304A. POLYSOMNOGRAPHY RELATED RESPIRATORY CARE. Practice Act defines
More informationISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ]
TITLE 16 CHAPTER 19 PART 26 OCCUPATIONAL AND PROFESSIONAL LICENSING PHARMACISTS PHARMACIST PRESCRIPTIVE AUTHORITY 16.19.26.1 ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque,
More informationArkansas Department of Health
Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer
More informationSENATE, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 8, 2016
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 0 Sponsored by: Senator JOSEPH F. VITALE District (Middlesex) SYNOPSIS Makes it a crime of the third degree to practice psychology without
More informationA Bill Regular Session, 2017 HOUSE BILL 1250
Stricken language would be deleted from and underlined language would be added to present law. 0 State of Arkansas st General Assembly As Engrossed: H// S// A Bill Regular Session, HOUSE BILL 0 By: Representative
More informationGuideline for the Rational Use of Controlled Drugs
Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import
More informationWhat Do IACP Members Think?
What Do IACP Members Think? Results of a National Survey of Compounding Practitioners February 27, 2013 Final Summary Results What Do Compounders Think? National Survey of 2,857 pharmacists and technicians
More informationOREGON MEDICAL MARIJUANA ACT
OREGON MEDICAL MARIJUANA ACT 475.300 Findings. The people of the state of Oregon hereby find that: (1) Patients and doctors have found marijuana to be an effective treatment for suffering caused by debilitating
More informationDrug and Alcohol Policy
CDL Program Drug and Alcohol Policy Effective as of [10/08/2018] Adopted by: Date Adopted: [10/08/2018] Last Revised: [10/08/2018] Table of Contents 1. Purpose of Policy... 3 2. Covered Employees... 3
More information2016 Dr. Douglas H. Kay CPE Symposium
GREGORY CAMERON, R.Ph ASSISTANT PROFESSOR OF PHARMACY PRACTICE FIELD COORDINATOR COMMUNITY SITES HUSSON UNIVERSITY SCHOOL OF PHARMACY November 5, 2016 Please Silence All Electronic Equipment OBJECTIVES
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)
H GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH0-MGfa-H* (01/) H.B. Mar, HOUSE PRINCIPAL CLERK D Short Title: Strengthen Opioid Misuse Prevention (STOP)Act. (Public) Sponsors: Referred to:
More informationOPIOID. Opioid Legislation FAQs NEED TO KNOW
OPIOID MICHIGAN OSTEOPATHIC ASSOCIATION APRIL 5, 2018 NEED TO KNOW Opioid Legislation FAQs These FAQs represent a compilation of questions received from MSMS and MAFP members. Please note that this is
More information78th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 964 SUMMARY
Sponsored by Senators BURDICK, KRUSE th OREGON LEGISLATIVE ASSEMBLY-- Regular Session Senate Bill SUMMARY The following summary is not prepared by the sponsors of the measure and is not a part of the body
More informationOverview of FDA Oversight and Enforcement on Drug Compounding
Overview of FDA Oversight and Enforcement on Drug Compounding Ruey Ju, Pharm.D., J.D. Senior Advisor for Compounding Compliance and Enforcement (Acting) Center for Drug Evaluation and Research Today s
More informationPHYSIOTHERAPY ACT AUTHORIZATION REGULATIONS
c t PHYSIOTHERAPY ACT AUTHORIZATION REGULATIONS PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this regulation, current to July 11, 2009. It is intended
More informationLobbyist-in-a-Box: (VPhAT) created on 01/15 at 10:11
Lobbyist-in-a-Box: (VPhAT) created on 01/15 at 10:11 HB 132 Controlled substances containing opioids; limits on prescription. Chief patron: Bell, John J. Limits on prescription of controlled substances
More information(A) results from that individual's participation in or training for sports, fitness training, or other athletic competition; or
VT AT Act 12/04 Title 26: Professions and Occupations Chapter 83: ATHLETIC TRAINERS 4151. Definitions As used in this chapter: (1) "Athlete" means any individual participating in fitness training and conditioning,
More informationCalifornia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationTRAUMA RECOVERY/HAP OPERATING GUIDELINES
TRAUMA RECOVERY/HAP OPERATING GUIDELINES FOR THE NATIONAL TRAUMA RECOVERY NETWORK, THE TRAUMA RECOVERY NETWORK ASSOCIATIONS, AND THE TRAUMA RECOVERY NETWORK CHAPTERS Operating Guidelines These Operating
More informationIC ARTICLE 20. HEARING AID DEALERS. IC Chapter 1. Regulation of Hearing Aid Dealers; Creation of Advisory Committee; Certificates
IC 25-20 ARTICLE 20. HEARING AID DEALERS IC 25-20-1 Chapter 1. Regulation of Hearing Aid Dealers; Creation of Advisory Committee; Certificates IC 25-20-1-1 Definitions Sec. 1. Except as the context requires
More informationSTATE OF MINNESOTA BOARD OF DENTISTRY GENERAL STATEMENT
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/sonar/sonar.asp STATE OF MINNESOTA
More information